Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank Regs Regulatory News (AXB)

Share Price Information for Axis Bank Regs (AXB)

Share Price is delayed by 15 minutes
Get Live Data
68.40    -0.40 (-0.58%)
Bid:
68.50
Ask:
68.70
Spread: 0.20 (0.292%)
Market Cap: $42.55b
AXB Live PriceLast checked at - London Stock Exchange

Intraday Axis Bank Regs Share Chart

  • This share is an international stock.

Issue of Equity

18 Dec 2017 13:59

RNS Number : 6762Z
Axis Bank Limited
18 December 2017
 

AXIS/CO/CS/726/2017-18

18th December 2017

 

Dear Sir,

SUB: ALLOTMENT OF EQUITY SHARES AND WARRANTS ON A PREFERENTIAL BASIS

 

REF: REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENT) REGULATIONS 2015.

 

This has reference to our letters AXIS/CO/CS/597/2017-18 dated 10th November 2017 and AXIS/CO/CS/685/2017-18 dated 8th December 2017, wherein we had informed you regarding outcome of the Board Meeting held on 10th November 2017 and outcome of the Extraordinary General Meeting of the Shareholders of the Bank held on 8th December 2017, respectively.

 

We are pleased to inform that the Committee of Whole-time Directors of the Bank at its meeting held today has pursuant to receipt of the consideration, approved the issuance and allotment of:

 

· 5,56,00,000 equity shares of face value of Rs. 2/- each (the "Investor 1 Equity Shares") to BC Asia Investments VII Limited (the "Investor 1"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 3,19,00,000 equity shares of face value of Rs. 2/- each (the "Investor 2 Equity Shares") to Integral Investments South Asia IV (the "Investor 2"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 4,00,00,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 3 Convertible Warrants") to BC Asia Investments III Limited (the "Investor 3"), on a preferential basis at a price of Rupees 565 per warrant.

 

· 59,98,000 equity shares of face value of Rs. 2/- each (the "Investor 4 Equity Shares") to New World Fund, Inc. (the "Investor 4"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 2,26,884 equity shares of face value of Rs. 2/- each (the "Investor 5 Equity Shares") to Capital Group New World Fund (LUX) (the "Investor 5"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

· 53,08,000 equity shares of face value of Rs. 2/- each (the "Investor 6 Equity Shares") to American Funds Insurance Series - International Fund (the "Investor 6"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 4,28,72,967 equity shares of face value of Rs. 2/- each (the "Investor 7 Equity Shares") to EuroPacific Growth Fund (the "Investor 7"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 5,65,899 equity shares of face value of Rs. 2/- each (the "Investor 8 Equity Shares") to American Funds Insurance Series - International Growth and Income Fund (the "Investor 8"), on a preferential basis at a price of Rupees 525 per Equity Share

 

· 27,86,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 4 Convertible Warrants") to Investor 4, on a preferential basis at a price of Rupees 565 per warrant.

 

· 1,05,385 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 5 Convertible Warrants") to Investor 5, on a preferential basis at a price of Rupees 565 per warrant.

 

· 24,66,000 warrants carrying an option to subscribe to an equivalent number of equity shares of Rs. 2/- each (the "Investor 6 Convertible Warrants") to Investor 6, on a preferential basis at a price of Rupees 565 per warrant.

 

· 2,28,57,142 equity shares of face value of Rs. 2/- each (the "Promoter Investor Equity Shares") to Life Insurance Corporation of India (the "Promoter Investor"), on a preferential basis at a price of Rupees 525 per Equity Share.

 

Pursuant to the allotment of the said equity shares, the total issued and paid up share capital of the Bank has increased from Rs. 479,71,01,600 (239,85,50,800 equity shares of Rs. 2/- each) to Rs. 512,77,59,384 (256,38,79,692 equity shares of Rs. 2/- each).

 

Please note that the Equity Shares allotted on a preferential basis as aforesaid rank pari passu with the existing equity shares of the Bank, in all respects.

 

Further, the equity shares and convertible warrants shall be under lock-in for such period as prescribed under the SEBI (Issue of Capital and Disclosures Requirement) Regulations, 2009.

 

You are requested to take note the above and arrange to bring it to the notice of all concerned.

 

Thanking you.

 

Yours Sincerely,

For Axis Bank Limited

 

 

 

Girish V Koliyote

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEGGGAAPUPMGWR
Date   Source Headline
12th May 202210:11 amRNSCredit Rating Action
29th Apr 20221:48 pmRNSOutcome of Board Meeting - April 29, 2022
28th Apr 20222:57 pmRNSDisclosure of Related Party Transactions
28th Apr 202212:51 pmRNSOutcome of Board Meeting held on April 28, 2022
25th Apr 20221:44 pmRNSEarnings call intimation
11th Apr 20223:54 pmRNSPostal Ballot Results
8th Apr 20225:12 pmRNSRATING ACTION BY CARE RATINGS LIMITED
8th Apr 20221:02 pmRNSINTIMATION FOR BOARD MEETING
7th Apr 20221:26 pmRNSRATING ACTION BY CRISIL RATINGS LIMITED
30th Mar 20221:04 pmRNSPurchase of Citibank’s India Consumer Business
29th Mar 202210:34 amRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
28th Mar 20222:23 pmRNSAmendments to Fair Disclosure Code
23rd Mar 20228:19 amRNSINVESTMENT IN OPEN NETWORK FOR DIGITAL COMMERCE
22nd Mar 20222:38 pmRNSGrant of Stock Options
9th Mar 202212:14 pmRNSNotice of Postal Ballot
7th Mar 20223:19 pmRNSResults of Postal Ballot
4th Feb 20227:00 amRNSNotice of postal ballot
25th Jan 20221:23 pmRNSRe-appointment of Chairman
24th Jan 202212:36 pmRNSFinancial Results for quarter - December 31, 2021
18th Jan 20222:23 pmRNSEarnings Call - Update on Financial Results
10th Jan 20221:00 pmRNSAppointment of Company Secretary
10th Jan 202212:58 pmRNSRe-appointment of Deputy Managing Director
29th Dec 20217:00 amRNSRE-DESIGNATION
22nd Dec 202111:28 amRNSAllotment of Securities
21st Dec 20217:00 amRNSReclassification of Promoter
20th Dec 20217:00 amRNSUpdates
20th Dec 20217:00 amRNSCessation of Director
16th Dec 202112:13 pmRNSBoard Meeting to consider Financial Results
15th Dec 20211:58 pmRNSRating Action By Crisil Ratings Limited
15th Dec 20211:46 pmRNSRating action by ICRA Limited
14th Dec 202112:57 pmRNSAppointment of Director
9th Dec 20211:16 pmRNSApproval of Grant of Stock Options
30th Nov 20211:04 pmRNSReclassification of Promoters
30th Nov 20217:00 amRNSFitch Ratings Action
29th Oct 20214:41 pmRNSSecond Price Monitoring Extn
29th Oct 20214:36 pmRNSPrice Monitoring Extension
27th Oct 20211:25 pmRNSRe-designation - Deputy Managing Director
26th Oct 20212:17 pmRNSRelated Party Disclosure
26th Oct 20211:54 pmRNSUnaudited Financial Results - 30.09.2021
21st Oct 20217:33 amRNSEarnings call - Financial Results of the Bank
14th Oct 20213:29 pmRNSRe-appointment of Managing Director & CEO
12th Oct 202112:52 pmRNSReclassification of Promoter
29th Sep 20211:46 pmRNSChange in Director(s)
15th Sep 202112:34 pmRNSReclassification of Promoter
8th Sep 20212:17 pmRNSNotes Allotment Intimation
7th Sep 20214:12 pmRNSRating Action by CARE Ratings
7th Sep 20213:50 pmRNSReclassification of Promoter
2nd Sep 20217:00 amRNSDisclosure - Reg. 30 of SEBI (LODR) Regulations
31st Aug 20216:27 pmRNSSchedule of Analyst / Investor Meeting
31st Aug 20217:00 amRNSSchedule of Analyst /Investor Meeting/Interactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.